FreeTender
Accepting bidsgrantUnited States

HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)

Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities

Published
20 Nov 2026
Closes
9 Mar 2027, 23:59 UTC
Value
USD 60,000,000
Reference
RFA-AI-28-004
Location
United States
Sector
Healthcare & Pharma

At a glance

National Institutes of Health in United States has published a funding call in healthcare & pharma: “HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)”. Submissions close on 9 March 2027, 109 days from today. The stated value is USD 60,000,000. Quote reference RFA-AI-28-004 in any correspondence with the buyer. FreeTender has recorded 463 notices from this buyer since 2023, 361 of them currently open. There are 367 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on Grants.gov (US federal)

Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.

Details

The purpose of this notice of funding opportunity (NOFO) is to support HIV/AIDS Clinical Trials Network Clinical Trials Units (CTUs). CTUs will provide the infrastructure, as well as the scientific and administrative expertise to conduct clinical studies developed by NIH HIV/AIDS Clinical Trials Networks to advance research in the prevention and treatment of HIV and HIV-associated diseases. CTUs will participate in multiple clinical research studies, accessing relevant populations most heavily impacted by the HIV/AIDS epidemic and studies of highest priority to NIH. Eligibility: Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Estimated total programme funding: USD 60000000

Expected number of awards: 65

CFDA number(s): 93.242

Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.

Context for bidders

We hold 463 notices from National Institutes of Health, going back to May 2023 — 361 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 367 open Healthcare & Pharma tenders in United States. This one closes in 109 days.

Explore United States

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →